Connect with others who understand.

sign up log in
Resources
About MyMSTeam
Powered By

What Are S1P Receptor Modulators?

Posted on July 23, 2021
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Brooke Dulka, Ph.D.

  • Sphingosine-1-phosphate (S1P) receptor modulators are a newer class of disease-modifying therapies that can be used to treat relapsing forms of multiple sclerosis (MS).
  • S1P receptor modulators are taken orally once or twice a day.
  • S1P receptor modulators are believed to work by reducing the activity of immune cells in the brain and spinal cord.

Although multiple sclerosis cannot yet be cured, there are medications that can slow its progression and reduce symptoms. In recent years, a newer class of disease-modifying therapy (DMT) known as sphingosine-1-phosphate receptor modulators have been approved to treat relapsing forms of MS.

S1P receptor modulators are drugs that help regulate the immune system. S1P receptor modulators are believed to work by blocking the S1P receptors found on the surface of lymphocytes — a type of white blood cell — that contribute to MS attacks. Generally, S1P receptor modulators are oral medications taken once or twice daily.

How Do S1P Receptor Modulators Work?

Receptors are like the “locks” on cells within the body, and antagonist drugs can function like “keys” to open them. S1P receptor modulators are believed to work via indirect antagonism of the S1P receptor.

An antagonist is a drug that reduces activity at a given receptor site. S1P receptor modulators are indirect antagonists because they don’t work on the receptor site directly, but bind to a different target that influences the S1P receptors’ activity.

The effect of S1P receptor modulators is to trap lymphocytes within the lymph nodes, away from the brain and spinal cord — also called the central nervous system or CNS. If lymphocytes can’t enter the CNS, they can’t contribute to MS attacks. There are several subtypes of S1P receptors, and each of the currently available S1P receptor modulators acts on the receptor subtypes differently. This leads to specific effects from each S1P receptor antagonist drug, making some S1P receptor modulators better options for one type of MS over another type.

What S1P Receptor Modulators Are Currently Available?

There are now several S1P receptor modulators approved to treat MS. These drugs include Gilenya (fingolimod), Mayzent (siponimod), Ponvory (ponesimod), and Zeposia (ozanimod).

S1P Receptor Modulators for Relapsing Forms of MS
Approved To Treat

Gilenya

(fingolimod)

Mayzent

(siponimod)

Ponvory

(ponesimod)

Zeposia

(ozanimod)

Clinically isolated syndrome (CIS) X X X X
Relapsing-remitting MS (RMSS) X X X X
Active secondary progressive MS (SPMS) X X X X
Sources Reference Reference Reference Reference

When Are S1P Receptor Modulators Prescribed?

These drugs are typically used for the treatment of various types of MS, which include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. These forms of MS may be characterized by attacks (or relapses) of new or increasing neurological symptoms. CIS can progress to RRMS, and RRMS can likewise progress to SPMS. Unless treated with DMTs, MS progression can lead to increases in disability and reduced quality of life.

Learn more about relapsing forms of MS.

According to the Consortium of Multiple Sclerosis Centers, any approved drug for MS can be prescribed as a first-line treatment for relapsing forms of MS. However, S1P receptor modulators are more likely to be prescribed for relapsing MS that seems to be progressing. This is because of the S1P receptor modulators’ mechanism of action. Specifically, by preventing lymphocytes from entering the central nervous system, MS progression can be slowed. This has been scientifically shown in phase 3 clinical trials of S1P drugs such as Mayzent, where a significant reduction in disability progression was observed compared to placebo.

Remember, although there is no cure for MS, DMTs are proven to slow MS disease progression. People with MS can live with an improved quality of life with DMTs, including S1P receptor modulators.

Read more about what to expect when starting an S1P receptor modulator.

Talk With Others Who Understand

MyMSTeam is the social network for people with multiple sclerosis and their loved ones. On MyMSTeam, more than 170,000 members come together to ask questions, give advice, and share their stories with others who understand life with multiple sclerosis.

Are you living with multiple sclerosis? Have you taken an S1P receptor modulator for your MS? Share your experience in the comments below, or start a conversation by posting on your Activities page.

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Brooke Dulka, Ph.D. is a freelance science writer and editor. She received her doctoral training in biological psychology at the University of Tennessee. Learn more about her here.

Related articles

Diphenhydramine, sold as Benadryl, is a type of antihistamine that can help reduce the likelihood...

Benadryl and MS: Why Is Benadryl Given With Some MS Treatments?

Diphenhydramine, sold as Benadryl, is a type of antihistamine that can help reduce the likelihood...
If you have multiple sclerosis (MS) and want to switch treatments, you may need to wait for one d...

What Is a Wash-Out Period? 8 Things To Know for DMTs

If you have multiple sclerosis (MS) and want to switch treatments, you may need to wait for one d...
As we learn more about multiple sclerosis (MS), researchers continue to look for new treatment op...

How Are New MS Medications Approved by the FDA? 6 Steps

As we learn more about multiple sclerosis (MS), researchers continue to look for new treatment op...
Between 40 percent and 65 percent of people with multiple sclerosis (MS) experience cognitive sym...

How Does Cognitive Rehabilitation for MS Work? 4 Ways It Can Help

Between 40 percent and 65 percent of people with multiple sclerosis (MS) experience cognitive sym...
Multiple sclerosis (MS) is an unpredictable disease, and most people living with it switch trea...

5 Things To Know When Switching MS Treatments

Multiple sclerosis (MS) is an unpredictable disease, and most people living with it switch trea...
Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing fo...

Switching DMTs for MS: 3 Signs It Might Be Time To Change

Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing fo...

Recent articles

Relapses, or periods of increased symptoms and disease activity, are common in relapsing forms of...

How Long Does an MS Relapse Last?

Relapses, or periods of increased symptoms and disease activity, are common in relapsing forms of...
Multiple sclerosis (MS) relapses are different for everyone.An MS relapse, or flare-up, is the ap...

What Does an MS Relapse Feel Like?

Multiple sclerosis (MS) relapses are different for everyone.An MS relapse, or flare-up, is the ap...
People with relapsing forms of multiple sclerosis (MS) may go through periods of new or worsening...

8 Symptoms of MS Relapse: How To Know if You’re Having a Flare

People with relapsing forms of multiple sclerosis (MS) may go through periods of new or worsening...
Maintaining independence is a concern for many people with multiple sclerosis (MS). And everyone ...

6 Resources for Independent Living and Managing MS

Maintaining independence is a concern for many people with multiple sclerosis (MS). And everyone ...
Multiple sclerosis (MS) is an autoimmune condition in which a person’s immune system attacks the...

How Damaged Myelin Affects Multiple Sclerosis

Multiple sclerosis (MS) is an autoimmune condition in which a person’s immune system attacks the...
When a person has advanced multiple sclerosis (MS), they experience extreme physical impairment a...

Advanced Multiple Sclerosis: 4 Symptoms and 8 Ways To Manage

When a person has advanced multiple sclerosis (MS), they experience extreme physical impairment a...
MyMSTeam My multiple sclerosis Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close